Better Therapeutics to Release Fourth Quarter and Full Year 2022 Financial Results and Provide Business Update on March 30, 2023

Rhea-AI Summary

Better Therapeutics, Inc. (NASDAQ: BTTX) will release its fourth quarter and full year 2022 financial results before market opening on March 30, 2023. The company develops prescription digital therapeutics focused on cognitive behavioral therapy to treat cardiometabolic diseases. Management will hold a conference call at 8:30 a.m. ET the same day to discuss business updates. Better Therapeutics aims to provide clinically validated mobile applications that can be prescribed by physicians, potentially improving patient outcomes while lowering healthcare costs. For future access, participants can register for the call via the provided link.

Positive

• Development of prescription digital therapeutics targeting cardiometabolic diseases.
• Conference call scheduled for March 30, 2023, to discuss financial results and business updates.

Negative

• None.

SAN FRANCISCO--(BUSINESS WIRE)-- Better Therapeutics, Inc. (NASDAQ: BTTX), a prescription digital therapeutics (PDT) company developing a clinically validated, software-based novel form of cognitive behavioral therapy to address the root causes of cardiometabolic diseases, today announced it will release its fourth quarter and full year 2022 financial results before the market opens on Thursday, March 30, 2023. Management will host a conference call and webcast to provide a business update at 8:30 a.m. ET / 5:30 a.m. PT on Thursday, March 30, 2023.

To access the conference call, please register at: https://register.vevent.com/register/BI24e91f91597f4f97a40e32c908ac7be5. Upon registering, each participant will be provided with call details and access codes. All participants are encouraged to join 10 minutes prior to the start time. The live webcast may be accessed by visiting the event link at: https://edge.media-server.com/mmc/p/cmdsh8s3. Following the webcast, a replay of the webcast may be accessed from the Presentations & Events page in the Investors section of the Better Therapeutics corporate website at: investors.bettertx.com.

About Better Therapeutics

Better Therapeutics is a prescription digital therapeutics company developing a novel form of cognitive behavioral therapy to address the root causes of cardiometabolic diseases. The company has developed a proprietary platform for the development of FDA-regulated, software-based solutions for type 2 diabetes, heart disease and other conditions. The CBT delivered by Better Therapeutics’ PDT is designed to enable changes in neural pathways of the brain so lasting changes in behavior become possible. Addressing the underlying causes of these diseases has the potential to dramatically improve patient health while lowering healthcare costs. Better Therapeutics’ clinically validated mobile applications, if authorized for marketing, are intended to be prescribed by physicians and reimbursed like traditional medicines.

For more information visit: bettertx.com

View source version on businesswire.com: https://www.businesswire.com/news/home/20230323005693/en/

Investor Relations:

Mark Heinen

IR@bettertx.com

Media Enquiries:

Emma Williams

emma.williams@bettertx.com

Source: Better Therapeutics, Inc.

FAQ

What are the upcoming financial results release dates for Better Therapeutics (BTTX)?

Better Therapeutics (BTTX) will release its fourth quarter and full year 2022 financial results on March 30, 2023.

What time is the Better Therapeutics (BTTX) conference call on March 30, 2023?

The conference call for Better Therapeutics (BTTX) is scheduled for 8:30 a.m. ET on March 30, 2023.

How can I access the Better Therapeutics (BTTX) conference call?

To access the Better Therapeutics (BTTX) conference call, please register at the link provided in the press release.